§01 Browse › UDCA

UDCA

Ursodeoxycholic Acid UDCA Actigall

None

Technical catalog description

UDCA (Ursodeoxycholic Acid) is another bile acid used for liver support, often combined with TUDCA for enhanced liver protection during extremely hepatotoxic cycles.

UDCA helps dissolve cholesterol-based gallstones and supports healthy bile flow. It’s typically used alongside TUDCA when running ultra-hepatotoxic compounds or multiple oral steroids simultaneously.

Overview Use context Comparison Safety
Warning
Usually combined with TUDCA for enhanced protection · Take with meals for better absorption

Read next

The Philosophy and Practice of Harm Reduction 9 min read
Overview

UDCA lives in the same practical lane as TUDCA: bile-flow support during periods when oral stress or cholestatic pressure are part of the picture. It is not glamorous, but that is exactly why it belongs in support planning rather than in the main story of the cycle.

The real value is usually in users who are already paying attention to liver markers and want a sensible support layer while exposure is active. It is far less useful for people who want to throw another supplement at an obviously bad oral stack instead of changing the stack.

Safety & monitoring
Side effects

  • GI upset, reflux, or loose stools

  • Similar false reassurance if the underlying oral load is not reduced

Monitoring

  • ALT / AST / GGT

  • bilirubin

Avoid if

  • Assuming support supplements replace safer compound selection

  • Known bile-duct issues unless medically directed

Use context

UDCA is chosen when the user wants an additional bile-acid based support option, whether alone or alongside TUDCA depending on the context and what is available. It tends to appeal to users who are trying to be methodical about liver management instead of just buying whatever is most hyped.

Timeline & expectations

Like TUDCA, this is judged by labs and tolerance, not by subjective feel. It is a background support compound. If liver markers still worsen rapidly, that is information about the cycle, not proof that the support “didn’t work.”

Common mistakes

The main mistake is stacking liver supports while refusing to reduce the actual insult. The second is interpreting normal labs on support as evidence that the oral stack was safe all along.

Comparison notes

Compared with TUDCA, UDCA is usually discussed less in PED communities, but the practical role is similar. Compared with simply removing the hepatotoxic driver, it remains the smaller lever.

Record quantities in the builder Read: The Philosophy and Practice of Harm Reduction ← Browse